Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:603392's PB Ratio is ranked worse than 54.07% of 1228
companies
in the Biotechnology industry
Industry Median: 2.78
vs SHSE:603392: 3.12
During the past 12 months, Beijing Wantai Biological Pharmacy Enterprise Co's average Book Value Per Share Growth Rate was -3.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -1.20% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 35.10% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 37.90% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Beijing Wantai Biological Pharmacy Enterprise Co was 90.60% per year. The lowest was -1.20% per year. And the median was 33.40% per year.
Back to Basics: PB Ratio
Beijing Wantai Biological Pharmacy Enterprise Co (SHSE:603392) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Beijing Wantai Biological Pharmacy Enterprise Co PB Ratio Related Terms
Beijing Wantai Biological Pharmacy Enterprise Co PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Wantai Biological Pharmacy Enterprise Co PB Ratio Chart
Beijing Wantai Biological Pharmacy Enterprise Co Annual Data
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beijing Wantai Biological Pharmacy Enterprise Co PB Ratio vs Biotechnology Industry
Beijing Wantai Biological Pharmacy Enterprise Co PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Beijing Wantai Biological Pharmacy Enterprise Co (SHSE:603392) has a PB Ratio of 3.12 as of Jul. 28, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Beijing Wantai Biological Pharmacy Enterprise Co and its competitors. This is 58% below median its historical median of 7.50. Over the past decade, Beijing Wantai Biological Pharmacy Enterprise Co's PB Ratio has ranged from 2.81 to 57.32. According to the industry distribution chart, Beijing Wantai Biological Pharmacy Enterprise Co ranks #664 out of 1228 companies in the Biotechnology industry, placing it in the top 54.1%.
Is Beijing Wantai Biological Pharmacy Enterprise Co's PB Ratio too high?
Beijing Wantai Biological Pharmacy Enterprise Co's current PB Ratio of 3.12 is 58% below median its 10-year median of 7.50. Over the past 10 years, this metric has ranged from a low of 2.81 to a high of 57.32. The Biotechnology industry median PB Ratio is 2.78. Beijing Wantai Biological Pharmacy Enterprise Co's value of 3.12 is 12.2% above this industry median. Based on the distribution chart, Beijing Wantai Biological Pharmacy Enterprise Co ranks #664 out of 1228 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Beijing Wantai Biological Pharmacy Enterprise Co has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Beijing Wantai Biological Pharmacy Enterprise Co's PB Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Beijing Wantai Biological Pharmacy Enterprise Co ranks #664 out of 1228 companies for PB Ratio. This places Beijing Wantai Biological Pharmacy Enterprise Co in the lower half of its industry. The industry median PB Ratio is 2.78. Beijing Wantai Biological Pharmacy Enterprise Co's value of 3.12 is 12.2% above this benchmark. Historically, Beijing Wantai Biological Pharmacy Enterprise Co's own PB Ratio has ranged from 2.81 to 57.32 over the past decade. While the company's 10-year median is 7.50 vs. the industry median of 2.78, Beijing Wantai Biological Pharmacy Enterprise Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.78, based on 1,228 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beijing Wantai Biological Pharmacy Enterprise Co's current PB Ratio of 3.12 is 12.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Beijing Wantai Biological Pharmacy Enterprise Co and its competitors. For the Biotechnology industry, the median PB Ratio is 2.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beijing Wantai Biological Pharmacy Enterprise Co's current PB Ratio is 3.12, which is 58% below median its own 10-year median of 7.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Wantai Biological Pharmacy Enterprise Co stock overvalued right now?
Based on GuruFocus' analysis, Beijing Wantai Biological Pharmacy Enterprise Co (SHSE:603392) is currently considered Possible Value Trap. The stock's GF Value™ is ¥42.09, compared to a current price of ¥29.20 — trading 30.6% below its estimated fair value. The current PB Ratio is 3.12, which is 58% below median its 10-year median of 7.50 and 12.2% above the Biotechnology industry median of 2.78. Beijing Wantai Biological Pharmacy Enterprise Co's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Beijing Wantai Biological Pharmacy Enterprise Co (SHSE:603392), the current PB Ratio is 3.12 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beijing Wantai Biological Pharmacy Enterprise Co (SHSE:603392) Overvalued in 2026?
Based on GuruFocus' analysis, Beijing Wantai Biological Pharmacy Enterprise Co stock appears to be undervalued.
The current stock price of ¥29.20 is trading 30.6% below its estimated GF Value™ of ¥42.09.
GuruFocus considers Beijing Wantai Biological Pharmacy Enterprise Co to be Possible Value Trap.
Key valuation signals for SHSE:603392:
PB Ratio: 3.12 (58% below median its 10-year median of 7.50)
GF Value™: ¥42.09 vs. price of ¥29.20 (30.6% below fair value)
Industry Position: 12.2% above the Biotechnology median (#664 of 1228)
No single metric tells the full story. See the SHSE:603392 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beijing Wantai Biological Pharmacy Enterprise Co Business Description
Beijing Wantai Biological Pharmacy Enterprise Co Ltd is engaged in research, development, production, and sales of in vitro diagnostic reagents, instruments, and vaccines. The company has two segments: Diagnostic and Vaccine. The Diagnostic segment develops and sells in vitro diagnostic reagents such as ELISA, colloidal gold, biochemical, and chemiluminescent kits, along with instruments including chemiluminescent analyzers, fluorescent analyzers, and nucleic acid purification systems. The Vaccine segment focuses on products like the hepatitis E vaccine, the bivalent HPV vaccine, and the nasal spray COVID-19 vaccine. It generates the majority of its revenue from the Diagnostic segment.
53GF Score
Get the complete analysis for SHSE:603392
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603392 has been successfully added to your 
